Lucira Health, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
0.50
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.38
|
-3.15
|
-2.77
|
-728.95%
|
|
2022-06-30
|
-0.34
|
-0.54
|
-0.20
|
-58.82%
|
|
2022-03-31
|
-0.08
|
0.31
|
0.39
|
487.50%
|
|
2021-12-31
|
-0.55
|
0.01
|
0.56
|
101.82%
|
|
2021-09-30
|
-0.51
|
-0.47
|
0.04
|
7.84%
|
|
2021-06-30
|
-0.32
|
-0.38
|
-0.06
|
-18.75%
|
|
2021-03-31
|
-0.33
|
-0.54
|
-0.21
|
-63.64%
|
|
2020-12-31
|
-0.80
|
-1.86
|
-1.07
|
-133.96%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.38
|
|
2021-12-31
|
-1.38
|
|
2020-12-31
|
-2.78
|